Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  


Here is the latest stock price and chart of AJANTA PHARMA. For more details, see the AJANTA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

LAST CHANCE: Watch Rahul Shah Reveal the Potential 10X Opportunity

Live BSE Quotes Jul 1, 2022 01:33:00 PM
Price (Rs)1,251.00 Open (Rs) 1,231.90 High (Rs) 1,258.00 Low (Rs) 1,231.10
% Change1.31 Volume 837 Value (Rs) 1,047,087 52-Week H/L 1,613.33 / 1,062.20
Live NSE Quotes Jul 1, 2022 1:34:58 PM
Price (Rs)1,250.00 Open (Rs) 1,233.00 High (Rs) 1,260.25 Low (Rs) 1,229.35
% Change1.17 Volume 36,201 Value (Rs) 45,196,224 52-Week H/L 1,623.33 / 1,061.77
1 Day
1 Month
3 Months
1 Year
5 Years (CAGR)*
10 Years (CAGR)*

* Compound Annual Growth Rate

EPS (Rs)* 55.62 P/E Ratio (x) 22.49 Market Cap (Rs m) 160,284.63 P/BV (x) 4.82 Dividend Yield (%) 0.76
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Peer Group:
Quote & Graph
Advanced Charts new
Charts by TradingView

AJANTA PHARMA Share Price Today:

AJANTA PHARMA last traded price was up 1.3% to Rs 1,251.0 on the BSE. On the NSE, AJANTA PHARMA last traded price was up 1.2% to Rs 1,250.0. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.2%. And the benchmark S&P BSE SENSEX was at 52,665.6 (down 0.7%).

Over the last 30 days, the AJANTA PHARMA share price is up 9.7%. And over the last one year, AJANTA PHARMA share price is down 10.0%.

The current market capitalisation of AJANTA PHARMA stands at Rs 160,284.63 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of March 2022, promoter pledging in AJANTA PHARMA stands at 16.60%. To know more, check out the latest shareholding pattern of AJANTA PHARMA.

What else is happening in the markets today? Dig in...


What is the AJANTA PHARMA share price today?

The last traded price of AJANTA PHARMA was Rs 1,251.0 on the BSE, up 1.3% over the previous close. On the NSE, AJANTA PHARMA last traded price was up 1.2% at Rs 1,250.0.

What is the market cap of AJANTA PHARMA?

The current market capitalisation of AJANTA PHARMA stands at Rs 160,285 m.

What is the Earnings per share (EPS) of AJANTA PHARMA?

AJANTA PHARMA had an EPS of Rs 55.6 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs 11.8.

What is the PE Ratio and PB Ratio of AJANTA PHARMA?

At the current price of Rs 1,251.0, AJANTA PHARMA trades at a PE ratio of 22.49 while its PB ratio stands at 4.82.

What is the Dividend Yield of AJANTA PHARMA?

For the financial year 2021, AJANTA PHARMA declared dividend amounting to Rs 9.5 per share. At the current price of Rs 1,251.0, this results in a dividend yield of 0.8%.

Today's Market

Sensex Tanks 750 Points as Energy, Auto Stocks Fall; Reliance, ONGC & Titan Top Losers(10:30 am)

Asian share markets erased early gains and fell in the negative territory tracking a sharp fall on Wall Street.

Related Views On News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks (Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022 Views On News (Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now (Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

How to Find the Next Multibagger Stock in the Market (Profit Hunter)

Jun 17, 2022

The #1 make or break factor in your portfolio you shouldn't ignore.

Is the Market Correction Over? (Fast Profits Daily)

Jun 17, 2022

In this video I'll show you why I think the market correction could be coming to an end.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks